Larvol Delta - Population-Pharmacokinetics-and-Safety-of-OPT302-an-AntiVEGFCD-39Trap39-in-Patients-With-Retinal-Vascular-Diseases

OPT-302 - Opthea

https://www.asrs.org/content/documents/pocket-guide-5.23.23pdf.pdf

Dante J. Pieramici, MD

Jul 4, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next